An additional marker, CD133, was identified for breast cancer stem cells isolated from cell lines generated from Brca1−exon11/p53+/− mouse mammary tumors [23] and is a known marker of cancer stem cells in several organs including brain, blood, liver and prostate [2], [3], [25], [26]. Here, TP53 is linked to breast cancer.